Custom Search

Combination Improves Survival of Metastatic Melanoma Patients: Phase II Study

Category: Cancer News RSS
Monday, June 04, 2007 at 5:46:58 PM
Bookmark and Share     Font Size 
CHICAGO – According to study findings presented today at the 2007 American Association of Clinical Oncology, two chemotherapy drugs combined with an agent that prevents the growth of blood vessels, significantly delayed the spread of tumors in patients with metastatic melanoma.

In this phase II clinical trial of 53 patients, tumor growth was delayed by almost six months, whereas, typically, these cancers begin spreading again eight weeks after chemotherapy treatment, researchers say.

The study was presented today by Domingo Perez, M.D., the lead author of the study who is a former oncology fellow at Mayo Clinic and is now in private practice in Minneapolis.

"The clinical benefit may seem small, but in the world of melanoma where there is very little progress, this is certainly a strong indication that the combination of chemotherapy with an antiangiogenic agent may be a valid treatment strategy for these patients. But the only way to know this for certain is a head to head comparison with the standard course of treatment," Dr. Perez says.

Melanoma that has metastasized (spread) to other parts of the body is one of the most difficult cancers to treat. Though rare, it is also the most deadliest of skin cancers because it does not respond well to chemotherapy. About one melanoma patient dies every hour (8,000 every year) in the United States, and 60,000 new cases are diagnosed annually, Dr. Markovic says.
Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Be the first to comment
* Your comment can be maximum of 2500 characters
Notify me when reply is posted   

Related Links

Medindia on Skin Cancer - Introduction
Skin cancer is a disease where malignant cells are found in the epidermis (outer layer of the skin). Skin cancers can develop due to a continuous exposure to sun over the years.

Read More...

For More Information
Researchers Develop Basis For Experimental Melanoma Treatment
Researchers Identify Immune Dysfunction in Melanoma Patients
Chances of Survival for Melanoma is High When Detected by Dermatologists

Medindia Health Network

Tweet this page Share this page
500 + Health news categories
Latest Health News From Leading Resources
Updated every 30 minutes
World Diabetes Day
Select a News Category
News Archive
Date :
Category :
Keyword :
Medindia on Facebook
Feedback  Advanced Search
Last Updated - - Designed & Content Managed by Medindia Health Network Pvt Ltd. Hosted & Technical Support by FrontPoint Systems
DisclaimerThe contents of this site are for informational purposes only. Always seek the advice of a qualified physician for any doubts.
To Read full Disclaimer Click Here!
Best viewed with resolution 1024x768 px.
Advertise with us |  Medindia Copyright |  Privacy Policy | Terms of Use |  © All Rights Reserved 1997 - 2009